Repetitive Transcranial Magnetic Stimulation for Post-concussion Headaches
State University of New York - Upstate Medical University · NCT06112093
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–55 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 1
- Target enrollment
- 60
- US sites recruiting
- 1
- Study start
- October 23, 2023
- Record last updated
- October 10, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study aims to examine the long-term effect of repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, on chronic headaches following mild traumatic brain injury (mTBI). rTMS has been shown to be effective in reducing chronic headaches without side effects commonly seen in medications, such as sleepiness and addiction. This study uses rTMS to manage chronic headaches to improve post-concussion symptoms and reduce the economic burden due to delayed recovery. This project aims to better identify biomarkers for diagnosis and prognosis and maximize recovery from mTBI.
Being studied: Repetitive Transcranial Magnetic Stimulation; Sham Repetitive Transcranial Magnetic Stimulation
Conditions: Brain Concussion; Mild Traumatic Brain Injury; Headache; Post-Concussion Symptoms
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 18 - 55 years old
- mTBI with loss of consciousness for less than 30 min, initial Glasgow Coma Scale between 13 and 15, or post-traumatic amnesia for ≤ 24 hours
- diagnosis of persistent post-traumatic headache according to the International Classification of Headache Disorders, 3rd edition (ICHD-3) criteria
- headache develops within 7 days after head trauma
- headache persists for >=3 months after head trauma despite receiving standard care
- average persistent headache intensity is >= 3/10 of the numerical rating scale (NRS) on >=3days/week
- no evidence of radiculopathy or peripheral neuropathy on electromyography or clinical evaluation
- no evidence of other possible causes of headaches
Exclusion Criteria
- history of chronic headache diagnoses such as migraine, tension, or cluster headaches prior to the incidence of mTBI
- history of other neurologic conditions with medications affecting the central nervous system
- contraindications of receiving TMS (e.g., a history of epileptic seizure and having implants like a cardiac pacemaker or intracerebral vascular clip
Recruiting US locations
SUNY Upstate Medical University
Syracuse, NY 13210
Site contact: Yi-Ling Kuo, PT, PhD · 3154646911 · kuoy@upstate.edu
Study contacts (from the official record)
- Yi-Ling Kuo, PT, PhD · 3154646911 · kuoy@upstate.edu
Similar studies in New York
All neurology studies in New York →- RecruitingHealthy volunteersPhase 1
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
Suninflam Inc
- Location
- Amherst, NY + 9 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersEarly Phase 1
Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or Paresis
Northwell Health
- Location
- Manhasset, NY
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteers
MyVitalC: Sleep and Everyday Headache Management
Efforia, Inc
- Location
- New York, NY
- Eligibility basics
- Any age listed
- RecruitingPhase 3
[18F]PI-2620 Phase 3 Histopathological Study
Lantheus Biosciences Ltd.
- Location
- Syracuse, NY + 16 other US sites
- Eligibility basics
- Ages 50+